Clinical use of plerixafor in combination with granulocyte-colony stimulating factor in hematopoietic stem cell transplantation
Cedar J Fowler1, Richard T Maziarz21Laboratory of Clinical Infectious Diseases – NIAID, National Institutes of Health, Bethesda, MD, USA; 2Adult Blood and Marrow Stem Cell Transplant Program, Oregon Health and Science University, Portland, OR, USAAbstract: Plerixafor is a CXC4:CXCL12 a...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2010-05-01
|
| Series: | Transplant Research and Risk Management |
| Online Access: | http://www.dovepress.com/clinical-use-of-plerixafor-in-combination-with-granulocyte-colony-stim-a4418 |